Kala pharmaceuticals inc.

Major-Pharmaceuticals

KALA


490 Arsenal Way
Watertown , MA 02472

Executive/
Director

Price

  • Last Close
  • $ 7.89
    $ +0.41 5.48 %
    Jan 3, 2025
  • 52-Week High/Low
  • $13.42 - $4.61
  • YTD
  • 11.6%

  • Trading Volume
  • 848
  • Market Cap Full
  • $ 21.2M
  • Shares Outstanding
  • 2.7M
    Nov 10, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - -14.4% 69.1% -5% -0.6% 14.1% -60.6% 12.1% 11.6%
Q2 - - -11.3% -24.6% 4% -21.4% -78.3% -3.1% -12.7% -
Q3 - 23.5% -26.3% -41.4% 8% -50.6% 3583.3% -39% -7.1% -
Q4 - -18.2% -49.2% -3.4% -12.8% -53.8% 245.3% -21.9% -7% -
J F M A M J J A S O N D
2025 11.6% - - - - - - - - - - -
2024 -0.7% 2% 10.7% -20% 7.2% 2.8% -4.8% -7.1% - - - 41.1%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-74%-24%82%-82%3053%-82%1%12%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.46 -0.75 -0.54 -0.49 -22.5 -6.99
Q2 - - -0.6 -0.7 -0.42 -0.57 -19 -4.36
Q3 - 0.56 -0.63 -0.68 -0.5 -0.43 19.25 -3.41
Q4 - 0.46 -0.8 -0.63 -0.53 -33.91 -7.23 -
A 0 1 -2.5 -2.8 -2 -108.3 -29.5 -14.76

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 33.9 36.8 61.6 72.6 2
Jun 24.6 33.9 55.7 64.6 72.6 2.3
Sep 24.6 34 56.1 65 73.2 2.5
Dec 33.8 34.5 56.1 65.5 1.5 2.7

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - 0.4 0.6 0.4 -
Fixed Asset Turnover - 0.8 0.3 0.3 -
Total Asset Turnover 0.1 0.1 - - -
Leverage
Debt Ratio 0.5 0.7 0.4 0.7 0.4
Debt – Equity Ratio 2.2 5 0.7 2.4 0.7
Interest Coverage 2.2 -10 -12 -14.7 -32.5
Equity multiplier - 0.8 0.2 0.6 0.1